Global Normothermic Perfusion of Isolated Organs Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07241761

Publication Date:

July 15, 2024

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Manufacturing (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

The global Normothermic Perfusion of Isolated Organs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淣ormothermic Perfusion of Isolated Organs Industry Forecast鈥� looks at past sales and reviews total world Normothermic Perfusion of Isolated Organs sales in 2022, providing a comprehensive analysis by region and market sector of projected Normothermic Perfusion of Isolated Organs sales for 2023 through 2029. With Normothermic Perfusion of Isolated Organs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Normothermic Perfusion of Isolated Organs industry.
This Insight Report provides a comprehensive analysis of the global Normothermic Perfusion of Isolated Organs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Normothermic Perfusion of Isolated Organs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Normothermic Perfusion of Isolated Organs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Normothermic Perfusion of Isolated Organs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Normothermic Perfusion of Isolated Organs.
United States market for Normothermic Perfusion of Isolated Organs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Normothermic Perfusion of Isolated Organs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Normothermic Perfusion of Isolated Organs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Normothermic Perfusion of Isolated Organs players cover TransMedics, Lung Bioengineering, OrganOx, XVIVO, TNO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Normothermic Perfusion of Isolated Organs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion
Segmentation by Application:
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion
Segmentation by Application:
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
TransMedics
Lung Bioengineering
OrganOx
XVIVO
TNO
UHN
SCREEN
Bridge to Life
Organ Recovery Systems
Institut Georges Lopez
Ebers
Penn Medicine
Johns Hopkins Medicine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Normothermic Perfusion of Isolated Organs Market Size 2025-2030
2.1.2 Normothermic Perfusion of Isolated Organs Market Size CAGR by Region
2.2 Normothermic Perfusion of Isolated Organs Segment by Type
2.2.1 Heart Perfusion
2.2.2 Liver Perfusion
2.2.3 Kidney Perfusion
2.2.4 Lung Perfusion
2.3 Normothermic Perfusion of Isolated Organs Market Size by Type
2.3.1 Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2025-2030)
2.3.2 Global Normothermic Perfusion of Isolated Organs Market Size Growth Rate by Type (2025-2030)
2.4 Normothermic Perfusion of Isolated Organs Segment by Application
2.4.1 Organ Transplant Specialist Hospitals
2.4.2 Organ Banks
2.4.3 Pharmaceutical Research Organizations
2.5 Normothermic Perfusion of Isolated Organs Market Size by Application (2025-2030)
2.5.1 Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2025-2030)
2.5.2 Global Normothermic Perfusion of Isolated Organs Market Size Growth Rate by Application (2025-2030)
3 Normothermic Perfusion of Isolated Organs Key Players
3.1 Date of Key Players Enter into Normothermic Perfusion of Isolated Organs
3.2 Key Players Normothermic Perfusion of Isolated Organs Product Offered
3.3 Key Players Normothermic Perfusion of Isolated Organs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Normothermic Perfusion of Isolated Organs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Normothermic Perfusion of Isolated Organs by Regions
4.1 Normothermic Perfusion of Isolated Organs Market Size by Regions (2025-2030)
4.2 United States Normothermic Perfusion of Isolated Organs Market Size Growth (2025-2030)
4.3 China Normothermic Perfusion of Isolated Organs Market Size Growth (2025-2030)
4.4 Europe Normothermic Perfusion of Isolated Organs Market Size Growth (2025-2030)
4.5 Rest of World Normothermic Perfusion of Isolated Organs Market Size Growth (2025-2030)
5 United States
5.1 United States Normothermic Perfusion of Isolated Organs Market Size by Type (2025-2030)
5.2 United States Normothermic Perfusion of Isolated Organs Market Size by Application (2025-2030)
6 Europe
6.1 Europe Normothermic Perfusion of Isolated Organs Market Size by Type (2025-2030)
6.2 Europe Normothermic Perfusion of Isolated Organs Market Size by Application (2025-2030)
7 China
7.1 China Normothermic Perfusion of Isolated Organs Market Size by Type (2025-2030)
7.2 China Normothermic Perfusion of Isolated Organs Market Size by Application (2025-2030)
8 Rest of World
8.1 Rest of World Normothermic Perfusion of Isolated Organs Market Size by Type (2025-2030)
8.2 Rest of World Normothermic Perfusion of Isolated Organs Market Size by Application (2025-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Normothermic Perfusion of Isolated Organs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 鈥︹€�
11 Key Players Analysis
11.1 TransMedics
11.1.1 TransMedics Company Details
11.1.2 TransMedics Normothermic Perfusion of Isolated Organs Product Offered
11.1.3 TransMedics Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.1.4 TransMedics Main Business Overview
11.1.5 TransMedics News
11.2 Lung Bioengineering
11.2.1 Lung Bioengineering Company Details
11.2.2 Lung Bioengineering Normothermic Perfusion of Isolated Organs Product Offered
11.2.3 Lung Bioengineering Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.2.4 Lung Bioengineering Main Business Overview
11.2.5 Lung Bioengineering News
11.3 OrganOx
11.3.1 OrganOx Company Details
11.3.2 OrganOx Normothermic Perfusion of Isolated Organs Product Offered
11.3.3 OrganOx Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.3.4 OrganOx Main Business Overview
11.3.5 OrganOx News
11.4 XVIVO
11.4.1 XVIVO Company Details
11.4.2 XVIVO Normothermic Perfusion of Isolated Organs Product Offered
11.4.3 XVIVO Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.4.4 XVIVO Main Business Overview
11.4.5 XVIVO News
11.5 TNO
11.5.1 TNO Company Details
11.5.2 TNO Normothermic Perfusion of Isolated Organs Product Offered
11.5.3 TNO Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.5.4 TNO Main Business Overview
11.5.5 TNO News
11.6 UHN
11.6.1 UHN Company Details
11.6.2 UHN Normothermic Perfusion of Isolated Organs Product Offered
11.6.3 UHN Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.6.4 UHN Main Business Overview
11.6.5 UHN News
11.7 SCREEN
11.7.1 SCREEN Company Details
11.7.2 SCREEN Normothermic Perfusion of Isolated Organs Product Offered
11.7.3 SCREEN Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.7.4 SCREEN Main Business Overview
11.7.5 SCREEN News
11.8 Bridge to Life
11.8.1 Bridge to Life Company Details
11.8.2 Bridge to Life Normothermic Perfusion of Isolated Organs Product Offered
11.8.3 Bridge to Life Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.8.4 Bridge to Life Main Business Overview
11.8.5 Bridge to Life News
11.9 Organ Recovery Systems
11.9.1 Organ Recovery Systems Company Details
11.9.2 Organ Recovery Systems Normothermic Perfusion of Isolated Organs Product Offered
11.9.3 Organ Recovery Systems Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.9.4 Organ Recovery Systems Main Business Overview
11.9.5 Organ Recovery Systems News
11.10 Institut Georges Lopez
11.10.1 Institut Georges Lopez Company Details
11.10.2 Institut Georges Lopez Normothermic Perfusion of Isolated Organs Product Offered
11.10.3 Institut Georges Lopez Normothermic Perfusion of Isolated Organs Market Size (2023 VS 2028)
11.10.4 Institut Georges Lopez Main Business Overview
11.10.5 Institut Georges Lopez News
11.11 Ebers
11.12 Penn Medicine
11.13 Johns Hopkins Medicine
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂